Ambev (ABEV) Expected to Release Quarterly Earnings on Thursday

Ambev (NYSE:ABEV) is projected to release its Q2 2026 results before the market opens on Thursday, July 30th. Analysts expect the company to announce earnings of $0.04 per share and revenue of $4.0531 billion for the quarter. Investors can find conference call details on the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Thursday, July 30, 2026 at 11:30 AM ET.

Ambev (NYSE:ABEV) last released its quarterly earnings results on Wednesday, May 6th. The company reported $0.05 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.05. The business had revenue of $4.32 billion during the quarter, compared to the consensus estimate of $4.38 billion. Ambev had a return on equity of 16.63% and a net margin of 17.69%. On average, analysts expect Ambev to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Ambev Price Performance

Shares of NYSE ABEV opened at $3.08 on Tuesday. The company has a current ratio of 1.03, a quick ratio of 0.78 and a debt-to-equity ratio of 0.02. The company’s 50-day moving average price is $3.14 and its 200 day moving average price is $3.02. Ambev has a 52 week low of $2.10 and a 52 week high of $3.45. The stock has a market cap of $48.47 billion, a price-to-earnings ratio of 16.19, a PEG ratio of 1.79 and a beta of 0.64.

Ambev Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, January 11th. Stockholders of record on Wednesday, June 24th will be given a $0.0092 dividend. The ex-dividend date is Wednesday, June 24th. This represents a $0.04 annualized dividend and a dividend yield of 1.2%. Ambev’s dividend payout ratio is currently 10.53%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on the stock. Scotiabank cut shares of Ambev from a “sector outperform” rating to a “sector perform” rating in a research note on Wednesday, July 15th. UBS Group upped their target price on Ambev from $2.65 to $2.90 and gave the company a “sell” rating in a research note on Thursday, May 14th. Wall Street Zen cut Ambev from a “buy” rating to a “hold” rating in a report on Monday, July 13th. Weiss Ratings cut Ambev from a “buy (b-)” rating to a “hold (c+)” rating in a report on Wednesday, May 6th. Finally, Barclays raised their price target on Ambev from $3.00 to $3.50 and gave the stock an “equal weight” rating in a research report on Wednesday, May 6th. Six analysts have rated the stock with a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Reduce” and a consensus target price of $3.09.

Insider Activity

In other news, insider Paulo Andre Zagman sold 136,250 shares of Ambev stock in a transaction dated Tuesday, May 5th. The shares were sold at an average price of $3.41, for a total transaction of $464,612.50. Following the completion of the sale, the insider directly owned 230,535 shares in the company, valued at $786,124.35. The trade was a 37.15% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

Hedge Funds Weigh In On Ambev

Several institutional investors and hedge funds have recently modified their holdings of ABEV. NewEdge Advisors LLC grew its stake in Ambev by 17.7% in the 4th quarter. NewEdge Advisors LLC now owns 23,578 shares of the company’s stock worth $58,000 after acquiring an additional 3,553 shares during the period. Federation des caisses Desjardins du Quebec lifted its stake in shares of Ambev by 4.4% during the 4th quarter. Federation des caisses Desjardins du Quebec now owns 100,451 shares of the company’s stock worth $248,000 after purchasing an additional 4,237 shares during the period. Blair William & Co. IL lifted its stake in shares of Ambev by 3.4% during the 3rd quarter. Blair William & Co. IL now owns 140,579 shares of the company’s stock worth $313,000 after purchasing an additional 4,557 shares during the period. Balyasny Asset Management L.P. boosted its holdings in shares of Ambev by 17.6% during the fourth quarter. Balyasny Asset Management L.P. now owns 32,513 shares of the company’s stock worth $80,000 after purchasing an additional 4,871 shares during the last quarter. Finally, Principal Securities Inc. boosted its holdings in shares of Ambev by 46.4% during the fourth quarter. Principal Securities Inc. now owns 19,593 shares of the company’s stock worth $48,000 after purchasing an additional 6,208 shares during the last quarter. Hedge funds and other institutional investors own 8.13% of the company’s stock.

Ambev Company Profile

Ambev (NYSE: ABEV) is a Brazilian-based beverage company that produces, distributes and markets a broad portfolio of alcoholic and non-alcoholic drinks. The company’s core business centers on brewing and selling beer, alongside a range of soft drinks, bottled water, energy drinks and other malt-based beverages. Headquartered in São Paulo, Ambev operates an integrated value chain that covers manufacturing, packaging, logistics and commercial sales to retail, on-premise and institutional customers.

The company traces its origins to the 1999 merger of two historic Brazilian breweries, and later became part of the broader global brewing group through subsequent industry consolidations.